Companies large and small are competing to attack rare genetic mutations that cause cancer. The reason? Great science and high drug prices. The result? Soaring stock prices.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2017/11/21/fighting-cancer-one-patient-at-a-time/
via IFTTT
No comments:
Post a Comment